Journey Medical Corporation announced impairment charges for the second quarter ended June 30, 2023. For the quarter, the company reported loss on impairment of intangible assets of $3,143,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | -0.55% | +0.56% | -37.67% |
13/05 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
13/05 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.67% | 7.21Cr | |
+31.37% | 59TCr | |
-2.60% | 36TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Announces Impairment Charges for the Second Quarter Ended June 30, 2023